IFM Therapeutics is a biopharmaceutical company. It is focused on the research and development of biological treatments for inflammatory diseases and cancer. The company's mission is to improve the lives of patients by developing small molecule drugs that target the innate immune system.
|Employees (est.) (Aug 2020)||31|
IFM Therapeutics total Funding
IFM Therapeutics latest funding size
Time since last funding
|8 months ago|
IFM Therapeutics investors
|Atlas Venture, Novartis, Abingworth, Omega Funds|
IFM Therapeutics has 568 Twitter Followers. The number of followers has increased 0.8% month over month and increased 3.5% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was IFM Therapeutics founded?
IFM Therapeutics was founded in 2017.
Who are IFM Therapeutics key executives?
IFM Therapeutics's key executives are Martin Seidel, Dennis Dean and William R. Roush.
How many employees does IFM Therapeutics have?
IFM Therapeutics has 31 employees.
Who are IFM Therapeutics competitors?
Competitors of IFM Therapeutics include Alligator Bioscience, Phoenix Biotechnology and Akrevia Therapeutics.
Where is IFM Therapeutics headquarters?
IFM Therapeutics headquarters is located at 855 Boylston St 11th floor, Boston.
Where are IFM Therapeutics offices?
IFM Therapeutics has an office in Boston.
How many offices does IFM Therapeutics have?
IFM Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies